Anika Therapeutics | ANIK - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Abbott USD 6.65B 787M 2026-06
Agenus USD 33.74M 468K 2026-03
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 75.25M 1.52M 2026-06
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Heron Therapeutics USD 29.47M 3.17M 2025-12
Insmed USD 356.19M 99.73M 2026-06
Integra LifeSciences USD 215.97M 2.77M 2026-06
Intrexon USD -297K 167K 2024-06
J&J USD 18.55B 1.31B 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Ligand Pharmaceuticals USD 100.41M 51.96M 2026-06
MacroGenics USD 11.24M 19.87M 2026-03
Merit Medical Systems USD 215.17M 30.37M 2026-06
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.71B 602M 2026-06
Smith & Nephew USD 2.09B 117M 2025-12
Stryker USD 4.5B 688M 2026-06
Veracyte USD 108.55M 7.39M 2026-06
Xencor USD 51.22M 46.7M 2026-06
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06